TrialTrials2017

Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.

Geoff Bellingan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.